StonvexLoading…
StonvexStonvexStonvexCore line items from AXTI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $26.92M | $88.33M | $65.28M | $37.33M |
Operating Income | $-1.58M | $-21.98M | $-18.14M | $-17.02M |
Net Income | $-1.62M | $-21.26M | $-17.71M | $-15.81M |
EPS (Diluted) | $-0.03 | $-0.49 | $-0.41 | $-0.36 |
Total Assets | $444.60M | $433.75M | $334.03M | $329.00M |
Total Liabilities | $107.63M | $99.12M | $93.58M | $88.37M |
Cash & Equivalents | $41.77M | $120.27M | $23.11M | $27.01M |
Free Cash Flow OCF − CapEx | $-13.06M | $-18.78M | $-20.04M | $-8.71M |
Shares Outstanding | 55.58M | 55.34M | 46.22M | 46.08M |